Progyny, Inc. Submits SEC Filing 144 – Find Out More About the Company and Form Type Here
Progyny, Inc. recently submitted a Form 144 with the Securities and Exchange Commission (SEC), indicating that certain individuals within the company may be planning to sell a portion of their shares. Form 144 is required to be filed with the SEC when insiders of a company, such as employees or executives, plan to sell their company’s stock. This filing does not necessarily mean that sales will occur immediately, as it serves as a notice of intent to sell.
Progyny, Inc. is a leading fertility benefits management company that specializes in helping employees navigate the complexities of family planning and fertility treatments. The company partners with employers to provide comprehensive fertility coverage, including in vitro fertilization (IVF), egg freezing, and other assisted reproductive technologies. Progyny’s mission is to make fertility treatment more accessible and affordable for individuals and couples seeking to start or expand their families.
For more information about Progyny, Inc. and its services, you can visit their official website at https://www.progyny.com/.
Read More:
Progyny, Inc. Submits SEC Filing 144 – Find Out More About It
